Anggot, Gregorio .
HRN: 01-24-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/03/2024
07/10/2024
IV
4.5grams
Q6hrs
Post Infection Bronchiectasis
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes